Latest Tenders From Kuwait

See procurement description
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient, allergen extract from birch pollen, ATC V01AA05, beabDAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient will come into force for the first time on November 1st, 2023det on October 31, 2025. Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. Active ingredient enoxaparin (only single potency-standard size combinationinations), ATC B01AB05, DAK-Gesundheit intends to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. Active ingredient appears for the first timein force on November 1st, 2023 and ends on October 31st, 2025. Regardless, it ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

The health insurance companies (whether HEK/hkk participate in the respective lot is determined by the name of the respective lot) pursue the goal of entering into discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the named active ingredients, combinations of active ingredients or dosage formen to conclude potencies. The contract is concluded as part of the open house procedure:
Individual negotiations about contract contents are not conducted; uniform conditions apply. The health insurance companies do not guarantee individual contractual partners exclusivity. The contract term isgenerally carries a maximum of 36 months starting on November 1st, 2023 at the earliest (if applicable, different start times can be found in the information for the relevant lot). The contract ends on October 31, 2026 at the latest (possible exceptions can be found in the information in the relevant lot), regardless of the dateof the conclusion of the contract. Joining this open house process is possible at any time within the contract period. All further information can be found in the participation and contract documents.
Doc Title: Pharmaceutical products
Contract Type: Supplies

LWETB wishes to establish a Dynamic Purchasing System (DPS) under fourteen (14) groups for provision of the Supply, Delivery, Assembly and/or installation of Furniture and Equipment for Longford and Westmeath Education and Training Board (LWETB) for the supply of the goods as described in Appendix 2 to this CFT (the “Goods”). The goods are required to be supplied and installed to any LWETB school or centre. The Goods comprise of furniture and equipment mostly based on specifications by the Department of Education (DE) for schools. Tenderers are invited to submit tenders for any or all groups. All of the Equipment must be supplied, unpacked and installed in allocated rooms and prices must include for this. Equipment to be commissioned and training provided, where appropriate and prices must include for this. The DPS will be in place for a minimum of six (6) years with an approximate spend of €6,000,000. Please note additional centres or schools may be added during the term of the Dynamic Purchasing System (DPS) at the discretion of LWETB.
Doc Title: Computer furniture
Contract Type: Supplies

Service contract relating to the provision of insurance for the needs of SERTRID

The health insurance companies (whether HEK/hkk participate in the respective lot is determined by the name of the respective lot) pursue the goal of entering into discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the named active ingredients, combinations of active ingredients or dosage formen to conclude potencies. The contract is concluded as part of the open house procedure:
Individual negotiations about contract contents are not conducted; uniform conditions apply. The health insurance companies do not guarantee individual contractual partners exclusivity. The contract term isgenerally carries a maximum of 24 months starting on November 1st, 2023 at the earliest (if applicable, different start times can be found in the information for the relevant lot). The contract ends on October 31, 2025 at the latest (possible exceptions can be found in the information in the relevant lot), regardless of the dateof the conclusion of the contract. Joining this open house process is possible at any time within the contract period. All further information can be found in the participation and contract documents.
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. The active ingredient, vericiguat, ATC C01DX22, is intended by DAK-GesunThe aim is to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into force for the first time on November 1st, 2023 and ends on October 31st, 2025. Heregardless of this, ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, seeet a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by DAK-Gesundheit. For medicines to be specified by the bidder in Annex 2 to the contract in relation to the above. The active ingredient, Lenograstim, ATC L03AA10, is intended by DAK-Gesund ability to conclude drug discount agreements with as many interested pharmaceutical companies as possible until new drug discount agreements come into force. A discount contract in the form of an approval model for the above-mentioned. The active ingredient comes into force for the first time on November 1st, 2023 and ends on October 31st, 2025. Heregardless of this, ends automatically when the exclusive contract comes into force.
Doc Title: Pharmaceutical products
Contract Type: Supplies

The object of the acquisition is a purchase service that supplements the Ostrobothnia welfare region's own home care.
The customers of home care are persons whose physical, psychological, social and/or cognitive function is either temporarily or permanently impaired and who need varying degrees of support at home ain the mentioned sub-areas. The customer groups are elderly people, long-term sick people, disabled people, intellectually disabled people, and mental health and substance abuse customers.has its own production, purchase service and service voucher. For own production, hired labor has been purchased for temporary needs.
There are an average of 30 customers within the scope of home care for the disabled (as a purchase service and with a service voucher), for whom the service is provided for approx. 2,500 hours per month. The number of customersis estimated to remain the same. The number of customers is an estimate and does not bind the Subscriber.
The customers are located in different parts of the area, they are in different age groups and with different service needs (20 hours/week 1054 hours/month). The number of customers varies and the number of new customers or the need for service cannot be controllednustaa.
Geographical area
This procurement concerns procurements for the entire welfare region of Ostrobothnia: the northern, central and southern regions. Services can be offered to one or more regions.
The northern region consists of the following municipalities in the Ostrobothnia welfare region: Kruunupyy, Luoto, Ped...